✦ LIBER ✦

Pilot Study of Bortezomib for Patients With Imatinib-Refractory Chronic Myeloid Leukemia in Chronic or Accelerated Phase

✍ Scribed by Fabio P.S. Santos; Hagop Kantarjian; David McConkey; Susan O'Brien; Stefan Faderl; Gautam Borthakur; Alessandra Ferrajoli; John Wright; Jorge Cortes

Book ID: 118032245
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 338 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.06.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot study of lonafarnib, a farnesyl tr

Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy

✍ Gautam Borthakur; Hagop Kantarjian; George Daley; Moshe Talpaz; Susan O'Brien; G 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

Efficacy of imatinib dose escalation in

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

✍ Hagop M. Kantarjian; Richard A. Larson; Francois Guilhot; Stephen G. O'Brien; Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 3 views

Dasatinib: From Treatment of Imatinib-Re

Dasatinib: From Treatment of Imatinib-Resistant or -Intolerant Patients With Chronic Myeloid Leukemia to Treatment of Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

✍ Brian L. Abbott 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Imatinib mesylate versus allogeneic BMT

Imatinib mesylate versus allogeneic BMT for patients with chronic myeloid leukemia in first chronic phase

✍ Bittencourt, H; Funke, V; Fogliatto, L; Magalhães, S; Setubal, D; Paz, A; Macedo 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 165 KB

Phase II study of low-dose decitabine in

Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia

✍ Yasuhiro Oki; Hagop M. Kantarjian; Vazganush Gharibyan; Dan Jones; Susan O'Brien 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

Erratum: Efficacy of imatinib dose escal

Erratum: Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

✍ Hagop M. Kantarjian; Richard A. Larson; Francois Guilhot; Stephen G. O'Brien; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views